ERITRODERMA AKIBAT REAKSI OBAT ALLOPURINOL

Authors

  • Pradissa Avia Emeralda General Practitioner, Departement of Dermatovenereology, dr.Moch.Ansari Saleh General Hospital Banjarmasin, South Borneo Indonesia
  • Dwiana Savitri Dermatovenerelogist, Departement of Dermatovenereology, dr.Moch.Ansari Saleh General Hospital Banjarmasin, South Borneo Indonesia

DOI:

https://doi.org/10.31004/prepotif.v8i2.32230

Keywords:

allopurinol, DRESS, drug reaction, erythroderma

Abstract

Erythroderma is a condition of generalized erythema and scaling of the skin. More than 90% of the body surface area are involved in this condition accompanied by a various degree of scaling. This is potentially life-threatening and has been associated with DRESS syndrome. 1,3 The aim of this case report is to discuss the allopurinol drug reaction as aetiology of erythroderma, its clinical manifestations and management of therapy. We report a case of a 55-year-old female patient who had a generalized erythema, pruritus, malaise and edema of her face since 7 days before admitted. She had history diabetes mellitus type 2, and was in oral allopurinol treatment for last 2 weeks. Extensive generalized erythematous plaques and hyperkeratotic scales were observed in the face, neck, chest, arms, legs, back, and gluteal.  Laboratory workup revealed peripheral blood eosinophilia, mild hypoalbuminemia, hyperglycemia, and elevated liver enzyme level.  She was hospitalized and got treatment with dermatologist and internist.  Erythroderma is an emergency case in dermatovenereology and in severe case it needs therapy and hospitalization to avoid complication. Management of erythroderma include discontinuing of any potential causative drug, maintaining skin moisture and integrity, adequate hydration and nutrition, maintaining electrolyte balance, and antibiotics for secondary infection.  Patient with drug-induced erythroderma with internal organ involvement has been associated with DRESS syndrome and needs further observation in cardiac, liver, and kidney status. Allopurinol is potential drug which can trigger erythroderma. Erythroderma is a life-threatening disease especially in severe case. It is important to increase awareness in allopurinol medication and need a careful assessment and treatment to avoid complication.

References

Cuellar-Barboza A, Ocampo-Candiani J, Herz-Ruelas M. A practical approach to the diagnosis and treatment of adult erythroderma. Actas Dermosifiliogr. 2018

Miyashiro D, Sanches, J.A. Erythroderma: a prospective study of 309 patients followed for 12 years in a tertiary center.Sci Rep. 2020; 10: 9774

Hoxha S, Fida M, Malaj R, et al. Erythroderma: A manifestation of cutaneous and systemic diseases. EMJ Allergy Immunol. 2020

Avandi B, Ghahartans M, Kashkooli NM, Ahramiyanpour N, Parvizi MM. Epidemiological and clinical features of hospitalized erythroderma patients: a cross-sectional study. Iranian Journal of Dermatology. 2022; 25(1): 60-65

Botella-Estradas R, Sanmartin O, Oeiver , et al. Erythroderma – a clinical pathological study of 56 cases. Arch Dermatol 1994; 130: 1503– 1507

Mistry N, Gupta A, Alavi A, Sibbald RG. A review of the diagnosis and management of erythroderma (generalized red skin). Advances in Skin and Wound Care. 2015; 28(5)

Htay MNN, Myint WW, Lwin H, et al. Allopurinol causing generalized exfoliative dermatitis: a case report. International Journal of basic & Clinical Pharmacology. 2017 Jul; 6(7): 1816-1819

Ozuguz P, Kacar D, Ozuguz U, et al. Erythroderma secondary to glicazide: a case report. Cutan Ocul Toxicol. 2014: 1-3

Harper-Kirksey, K. Erythroderma. Life-Threatening Rashes. 2018; 265–277

Sharma G, Govil DC. Allopurinol induced erythroderma. Indian J Pharmacol. 2013; 45: 627-8

Shiohara T, Kano Y. Drug reaction with eosinophilia and systemic symptoms (DRESS): incidence, pathogenesis, and management. Expert Opinion on Drug Safety. 2017; 16(2): 139-147

Vanini A, Hutomo M. Manifestasi klinis sindroma DRESS (Drug Reaction with Eosinophilia and Systemic Symptom). Berkala Ilmu Kesehatan Kulit & Kelamin. 2010; 22(1)

Jobarteh R, Peng YE, Soni A, Gelber AC, O’Rourke PD. Generalized erythroderma with fever. The American Journal of Medicine. 2020; 133(7)

Anggraini DR, Pasaribu SD. Laporan Kasus: Pria 60 tahun dengan Eritroderma et causa Dermatitis Seboroik. Majalah Kedokteran UKI. 2021; 37(1)

Maharani S, Setyaningrum T. Profil pasien eritroderma. Berkala Ilmu Kesehatan Kulit dan Kelamin. 2017; 29(1)

Miranti U, Misturiansyah NI, Nuridah AL, Amien MI, Yoga RR. Diagnosis dan tata laksana eritroderma. Cermin Dunia Kedokteran. 2024; 51(6)

Khaled A, Sellami A, Fazaa B, Kharfi M, Zeglaoui F, Kamoun MR . Acquired erythroderma in adults: a clinical and prognostic study. J Eur Acad Dermatol Venereol. 2010;24(7):781-8

Downloads

Published

2024-08-31

How to Cite

Emeralda, P. A. ., & Savitri, D. . (2024). ERITRODERMA AKIBAT REAKSI OBAT ALLOPURINOL. PREPOTIF : JURNAL KESEHATAN MASYARAKAT, 8(2), 4642–4649. https://doi.org/10.31004/prepotif.v8i2.32230